rheumatology
Rheumatoid arthritis

PBS listings recommended for new bDMARD and two new biosimilars

The biological DMARD baricitinib (Olumiant) has been recommended for listing on the PBS as an alternative option to currently PBS-listed bDMARDs for severe RA. The drug overcame concerns raised about safety when its application was initially evaluated by the PBAC, which deferred its decision pending a TGA review. “The PBAC was of a mind to ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic